{
  "id": "nature-aging",
  "title": "Nature Aging",
  "summary": "Nature Aging, Published online: 03 February 2026; doi:10.1038/s43587-025-01052-4Senescence is a double-edged sword in cancer therapy, capable of driving tumor-promoting and tumor-suppressive responses. In this issue of Nature Aging, González-Gualda, Reinius and colleagues identify activation of TGFβ signaling as the key protumorigenic activity and a viable therapeutic target within the senescence program triggered by platinum-based chemotherapy in ovarian and lung cancers.",
  "url": "http://feeds.nature.com/nataging/rss/current",
  "source": "Nature Aging",
  "author": "Saima Hassan",
  "category": "research",
  "publishedAt": "2026-02-03T00:00:00.000Z",
  "fetchedAt": "2026-02-04T10:50:09.335Z",
  "relevanceScore": 0.5,
  "matchedKeywords": [
    "aging",
    "senescence"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:50:09.363Z"
}